The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
The emerging role of CXCL10 in cancer (Review)
Open accessAbstract
The chemokine interferon-γ inducible protein 10 kDa (CXCL10) is a member of the CXC chemokine family which binds to the CXCR3 receptor to exert its biological effects. CXCL10 is involved in chemotaxis, induction of apoptosis, regulation of cell growth and mediation of angiostatic effects. CXCL10 is associated with a variety of human diseases including infectious diseases, chronic inflammation, immune dysfuntion, tumor development, metastasis and dissemination. More importantly, CXCL10 has been identified as a major biological marker mediating disease severity and may be utilized as a prognostic indicator for various diseases. In this review, we focus on current research elucidating the emerging role of CXCL10 in the pathogenesis of cancer. Understanding the role of CXCL10 in disease initiation and progression may provide the basis for developing CXCL10 as a potential biomarker and therapeutic target for related human malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Rice, D., & Barone, S. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s3511 · Cited by 2,944
Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,311
Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.129 · Cited by 2,014
Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes
Sallusto, F., Lenig, D., Mackay, C. R., & Lanzavecchia, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.6.875 · Cited by 1,542
Reverse engineering of regulatory networks in human B cells
Basso, K., Margolin, A. A., Stolovitzky, G., Klein, U., Dalla-Favera, R., & Califano, A. (2005) · Nature Genetics · doi:10.1038/ng1532 · Cited by 1,404
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
Astrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304
Lymphocyte traffic control by chemokines
Moser, B., & Loetscher, P. (2001) · Nature Immunology · doi:10.1038/84219 · Cited by 1,240
Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.963 · Cited by 1,193
Rosenwald, A., Alizadeh, A. A., Widhopf, G., Simon, R., Davis, R. E., Yu, X., Yang, L., Pickeral, O. K., Rassenti, L. Z., Powell, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.11.1639 · Cited by 1,097
Luster, A. D., Unkeless, J. C., & Ravetch, J. V. (1985) · Nature · doi:10.1038/315672a0 · Cited by 944
Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain
Sun, L., Hui, A.-M., Su, Q., Vortmeyer, A., Kotliarov, Y., Pastorino, S., Passaniti, A., Menon, J., Walling, J., Bailey, R., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.003 · Cited by 877
Cole, K. E., Strick, C. A., Paradis, T. J., Ogborne, K. T., Loetscher, M., Gladue, R. P., Lin, W., Boyd, J. G., Moser, B., Wood, D. E., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2009 · Cited by 870
X chromosomal abnormalities in basal-like human breast cancer
Richardson, A. L., Wang, Z. C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J. D., Livingston, D. M., & Ganesan, S. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.013 · Cited by 869
CXC chemokines in angiogenesis
Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., & Strieter, R. M. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.1.1 · Cited by 804
Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma†
Wurmbach, E., Chen, Y., Khitrov, G., Zhang, W., Roayaie, S., Schwartz, M., Fiel, I., Thung, S., Mazzaferro, V., Bruix, J., et al. (2007) · Hepatology · doi:10.1002/hep.21622 · Cited by 722
Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.
Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. M., Maheshwari, S., Kleinman, H. K., Reaman, G. H., & Tosato, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.155 · Cited by 705
Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).
Luster, A. D., & Ravetch, J. V. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.1084 · Cited by 666
Sanchez-Carbayo, M., Socci, N. D., Lozano, J., Saint, F., & Cordon-Cardo, C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2375 · Cited by 550
Pyeon, D., Newton, M. A., Lambert, P. F., den Boon, J. A., Sengupta, S., Marsit, C. J., Woodworth, C. D., Connor, J. P., Haugen, T. H., Smith, E. M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3619 · Cited by 460
The gene expression signatures of melanoma progression
Haqq, C., Nosrati, M., Sudilovsky, D., Crothers, J., Khodabakhsh, D., Pulliam, B. L., Federman, S., Miller, J. R., Allen, R. E., Singer, M. I., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501564102 · Cited by 433
Beroukhim, R., Brunet, J.-P., Di Napoli, A., Mertz, K. D., Seeley, A., Pires, M. M., Linhart, D., Worrell, R. A., Moch, H., Rubin, M. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0146 · Cited by 412
CXC chemokines: the regulatory link between inflammation and angiogenesis
Romagnani, P., Lasagni, L., Annunziato, F., Serio, M., & Romagnani, S. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.02.006 · Cited by 409
Ginos, M. A., Page, G. P., Michalowicz, B. S., Patel, K. J., Volker, S. E., Pambuccian, S. E., Ondrey, F. G., Adams, G. L., & Gaffney, P. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2144 · Cited by 407
Donor-Derived Ip-10 Initiates Development of Acute Allograft Rejection
Hancock, W. W., Gao, W., Csizmadia, V., Faia, K. L., Shemmeri, N., & Luster, A. D. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.8.975 · Cited by 373
CXCL10 and autoimmune diseases
Lee, E. Y., Lee, Z.-H., & Song, Y. W. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.12.002 · Cited by 357
Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization
Loetscher, M., Loetscher, P., Brass, N., Meese, E., & Moser, B. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199811)28:11<3696::aid-immu3696>3.0.co;2-w · Cited by 357
Neville, L. F., Mathiak, G., & Bagasra, O. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00015-4 · Cited by 350
Gumz, M. L., Zou, H., Kreinest, P. A., Childs, A. C., Belmonte, L. S., LeGrand, S. N., Wu, K. J., Luxon, B. A., Sinha, M., Parker, A. S., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0143 · Cited by 297
Korkola, J. E., Houldsworth, J., Chadalavada, R. S. V., Olshen, A. B., Dobrzynski, D., Reuter, V. E., Bosl, G. J., & Chaganti, R. S. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2445 · Cited by 292
IP-10 Is Critical for Effector T Cell Trafficking and Host Survival in Toxoplasma gondii Infection
Khan, I. A., MacLean, J. A., Lee, F. S., Casciotti, L., DeHaan, E., Schwartzman, J. D., & Luster, A. D. (2000) · Immunity · doi:10.1016/s1074-7613(00)80200-9 · Cited by 281
Intracellular Domains of CXCR3 That Mediate CXCL9, CXCL10, and CXCL11 Function
Colvin, R. A., Campanella, G. S. V., Sun, J., & Luster, A. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403595200 · Cited by 274
Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes
Kawada, K., Hosogi, H., Sonoshita, M., Sakashita, H., Manabe, T., Shimahara, Y., Sakai, Y., Takabayashi, A., Oshima, M., & Taketo, M. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210267 · Cited by 243
Whole genome analysis for liver metastasis gene signatures in colorectal cancer
Ki, D. H., Jeung, H., Park, C. H., Kang, S. H., Lee, G. Y., Lee, W. S., Kim, N. K., Chung, H. C., & Rha, S. Y. (2007) · International Journal of Cancer · doi:10.1002/ijc.22975 · Cited by 235
Yusenko, M. V., Kuiper, R. P., Boethe, T., Ljungberg, B., van Kessel, A. G., & Kovacs, G. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-152 · Cited by 228
Skotheim, R. I., Lind, G. E., Monni, O., Nesland, J. M., Abeler, V. M., Fosså, S. D., Duale, N., Brunborg, G., Kallioniemi, O., Andrews, P. W., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0153 · Cited by 198
Jones, D., Benjamin, R. J., Shahsafaei, A., & Dorfman, D. M. (2000) · Blood · doi:10.1182/blood.v95.2.627 · Cited by 190
Structure-Function Relationship between the Human Chemokine Receptor CXCR3 and Its Ligands
Clark-Lewis, I., Mattioli, I., Gong, J.-H., & Loetscher, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209470200 · Cited by 189
Andersson, A., Ritz, C., Lindgren, D., Edén, P., Lassen, C., Heldrup, J., Olofsson, T., Råde, J., Fontes, M., Porwit-MacDonald, A., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404688 · Cited by 189
IL‐18 enhances IFN‐γ‐induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes
Kanda, N., Shimizu, T., Tada, Y., & Watanabe, S. (2007) · European Journal of Immunology · doi:10.1002/eji.200636420 · Cited by 169
Datta, D., Flaxenburg, J. A., Laxmanan, S., Geehan, C., Grimm, M., Waaga-Gasser, A. M., Briscoe, D. M., & Pal, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4345 · Cited by 161
Inhibition of endothelial cell survival and angiogenesis by protein kinase A
Kim, S., Bakre, M., Yin, H., & Varner, J. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14268 · Cited by 160
Detwiller, K. Y., Fernando, N. T., Segal, N. H., Ryeom, S. W., D'Amore, P. A., & Yoon, S. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4078 · Cited by 151
Chemokine Receptor CXCR3: An Unexpected Enigma
Liu, L., Callahan, M. K., Huang, D., & Ransohoff, R. M. (2005) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(05)68006-4 · Cited by 150
Inhibition of endothelial cell survival and angiogenesis by protein kinase A
Kim, S., Bakre, M. M., Yin, H. X., & Varner, J. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214268 · Cited by 150
Talbot, S. G., Estilo, C. L., Maghami, E. G., Sarkaria, I. S., Ceppa, D. P., O‐charoenrat, P., Socci, N. D., Ngai, I. M., Carlson, D. L., Ghossein, R. A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1985 · Cited by 144
The CXCR3 Binding Chemokine IP-10/CXCL10: Structure and Receptor Interactions
Booth, V. K., Keizer, D. W., Kamphuis, M. B., Clark‐Lewis, I., & Sykes, B. D. (2002) · Biochemistry · doi:10.1021/bi026020q · Cited by 144
Maru, S., Holloway, K., Flynn, G., Lancashire, C. L., Loughlin, J., Male, D. K., & Romero, I. A. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.029 · Cited by 121
CXCR3/Ligands Are Significantly Involved in the Tumorigenesis of Basal Cell Carcinomas
Lo, B. K. K., Yu, M., Zloty, D. M., Cowan, B. J., Shapiro, J., & McElwee, K. J. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.081059 · Cited by 116
Shahabuddin, S., Ji, R., Wang, P., Brailoiu, E., Dun, N. J., Yang, Y., Aksoy, M. O., & Kelsen, S. G. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00441.2005 · Cited by 113
Furuya, M., Suyama, T., Usui, H., Kasuya, Y., Nishiyama, M., Tanaka, N., Ishiwata, I., Nagai, Y., Shozu, M., & Kimura, S. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.03.023 · Cited by 109
Fujita, M., Zhu, X., Ueda, R., Sasaki, K., Kohanbash, G., Kastenhuber, E. R., McDonald, H. A., Gibson, G. A., Watkins, S. C., Muthuswamy, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2915 · Cited by 108
Mee, J. B., Johnson, C. M., Morar, N., Burslem, F., & Groves, R. W. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061067 · Cited by 106
Oligomerization of CXCL10 Is Necessary for Endothelial Cell Presentation and In Vivo Activity
Campanella, G. S. V., Grimm, J., Manice, L. A., Colvin, R. A., Medoff, B. D., Wojtkiewicz, G. R., Weissleder, R., & Luster, A. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6991 · Cited by 106
Luster, A. D., Jhanwar, S. C., Chaganti, R. S. K., Kersey, J. H., & Ravetch, J. V. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.2868 · Cited by 104
Monteagudo, C. C., Martín, J. M., Jordá, E., & Llombart‐Bosch, A. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.032144 · Cited by 104
Dyer, K. D., Percopo, C. M., Fischer, E. R., et al. (2009) · Blood · doi:10.1182/blood-2009-01-199497 · Cited by 97
Agonistic and antagonistic activities of chemokines
Loetscher, P., & Clark‐Lewis, I. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.881 · Cited by 96
Enderlin, M., Kleinmann, E. V., Struyf, S., Buracchi, C., Vecchi, A., Kinscherf, R., Kiessling, F. M., Paschek, S., Sozzani, S., Rommelaere, J., et al. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.62 · Cited by 95
Crystal Structures of Oligomeric Forms of the IP-10/CXCL10 Chemokine
Swaminathan, G. J., Holloway, D. E., Colvin, R. A., Campanella, G. K., Papageorgiou, A. C., Luster, A. D., & Acharya, K. R. (2003) · Structure · doi:10.1016/s0969-2126(03)00070-4 · Cited by 90
Kanda, N., & Watanabe, S. (2007) · Endocrinology · doi:10.1210/en.2006-1639 · Cited by 84
Giuliani, N., Bonomini, S., Romagnani, P., Lazzaretti, M., Morandi, F., Colla, S., Tagliaferri, S., Lasagni, L., Annunziato, F., Crugnola, M., et al. (2006) · PubMed · Cited by 84
Nakamichi, K., Saiki, M., Sawada, M., Takayama‐Ito, M., Yamamuro, Y., Morimoto, K., & Kurane, I. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.11801-11812.2005 · Cited by 83
Aksoy, M. O., Yang, Y., Ji, R., Reddy, P. J., Shahabuddin, S., Litvin, J., Rogers, T. J., & Kelsen, S. G. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00430.2005 · Cited by 82
CXCL10 expression and prognostic significance in stage II and III colorectal cancer
Jiang, Z., Xu, Y., & Cai, S. (2009) · Molecular Biology Reports · doi:10.1007/s11033-009-9873-z · Cited by 76
Anti-angiogenic gene therapy of cancer: Current status and future prospects
Persano, L., Crescenzi, M., & Indraccolo, S. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.12.005 · Cited by 75
Nakamichi, K., Inoue, S., Takasaki, T., Morimoto, K., & Kurane, I. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9376-9388.2004 · Cited by 65
van Weering, H. R. J., Boddeke, H. W. G. M., Vinet, J., Brouwer, N., Haas, A. H. D., van Rooijen, N., Thomsen, A. R., & Biber, K. P. H. (2010) · Hippocampus · doi:10.1002/hipo.20742 · Cited by 62
MAP kinase regulation of IP10/CXCL10 chemokine gene expression in microglial cells
Shen, Q., Zhang, R., & Bhat, N. R. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.116 · Cited by 59
CXCR3-binding chemokines in multiple myeloma
Pellegrino, A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.10.036 · Cited by 55
The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10
Lü, X., Jiang, X., Liu, R., & Zhang, S. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.08.012 · Cited by 41
Brain Tumor Immunotherapy with Type‐1 Polarizing Strategies
Okada, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04932.x · Cited by 41
Molecular Classification of Parathyroid Neoplasia by Gene Expression Profiling
Morrison, C., Farrar, W. B., Kneile, J., Williams, N., Liu-Stratton, Y., Bakaletz, A. P., Aldred, M. A., & Eng, C. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63321-4 · Cited by 39
Yang, L., Chen, P., Luo, S., Li, J., Liu, K., Huo-zhen, H., & Wei, Y. (2009) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20090012 · Cited by 35
Human type II pneumocyte chemotactic responses to CXCR3 activation are mediated by splice variant A
Ji, R., Lee, C. M., Gonzales, L. W., Yang, Y., Aksoy, M. O., Wang, P., Brailoiu, E., Dun, N. J., Hurford, M. T., & Kelsen, S. G. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00388.2007 · Cited by 31
Jiang, X., Lü, X., Hu, P., & Liu, R. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.002 · Cited by 29
Aronica, S. M., Raiber, L., Hanzly, M. I., & Kisela, C. (2008) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0034 · Cited by 27
Expression of CXCL10 in cultured cortical neurons
Vinet, J., de Jong, E. K., Boddeke, H. W. G. M., Stanulovic, V., Brouwer, N., Granic, I., Eisel, U. L. M., Liem, R. S. B., & Biber, K. P. H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06495.x · Cited by 25
Aronica, S. M., Fanti, P., Kaminskaya, K., Gibbs, K., Raiber, L., Nazareth, M. R., Bucelli, R. C., Mineo, M., Grzybek, K., Kumin, M., et al. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000019961.59306.f6 · Cited by 23
Kang, T. H., Bae, H. C., Kim, S., Seo, S. H., Son, S. W., Choi, E. Y., Seong, S., & Kim, T. W. (2009) · The Journal of Gene Medicine · doi:10.1002/jgm.1371 · Cited by 23
Structure of mouse IP-10, a chemokine
Jabeen, T., Leonard, P. M., Jamaluddin, H., & Acharya, K. R. (2008) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444908007026 · Cited by 20
Cited by
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Brown, C. E., Alizadeh, D., Starr, R., Weng, L., Wagner, J. R., Naranjo, A., Ostberg, J. R., Blanchard, M. S., Kilpatrick, J., Simpson, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610497 · Cited by 1,836
Tohme, S., Yazdani, H. O., Al-Khafaji, A. B., Chidi, A. P., Loughran, P., Mowen, K., Wang, Y., Simmons, R. L., Huang, H., & Tsung, A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1591 · Cited by 694
Kitai, Y., Kawasaki, T., Sueyoshi, T., Kobiyama, K., Ishii, K. J., Zou, J., Akira, S., Matsuda, T., & Kawai, T. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601694 · Cited by 318
Schulz, D., Zanotelli, V. R. T., Fischer, J. R., Schapiro, D., Engler, S., Lun, X.-K., Jackson, H. W., & Bodenmiller, B. (2018) · Cell Systems · doi:10.1016/j.cels.2017.12.001 · Cited by 280
Chen, H., Pan, Y., Zhou, Q., Liang, C., Wong, C.-C., Zhou, Y., Huang, D., Liu, W., Zhai, J., Gou, H., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.024 · Cited by 277
Metadata
- Authors
- LIU, M., GUO, S., & STILES, J. K.
- Venue
- Oncology Letters
- Publisher
- Spandidos Publications
- Published
- 2011-05-09
- Volume
- 2
- Issue
- 4
- Pages
- 583-589
- ISSN
- 1792-1074 (ISSN-L)
- 1792-1082
- OpenAlex
- W2094650342
- Cited by
- 411
- References
- 85
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.